116 related articles for article (PubMed ID: 35104762)
1. Dihydroartemisinin enhances the anti-tumor activity of oxaliplatin in colorectal cancer cells by altering PRDX2-reactive oxygen species-mediated multiple signaling pathways.
Yu Y; Chen D; Wu T; Lin H; Ni L; Sui H; Xiao S; Wang C; Jiang S; Pan H; Li S; Jin X; Xie C; Cui R
Phytomedicine; 2022 Apr; 98():153932. PubMed ID: 35104762
[TBL] [Abstract][Full Text] [Related]
2. Regorafenib activates oxidative stress by inhibiting SELENOS and potentiates oxaliplatin-induced cell death in colon cancer cells.
Yu Y; Wu T; Zhang X; Li P; Ye L; Kuang J; Tao L; Ni L; Zhao Q; Zhang J; Pan H; Xie C; Zheng C; Li S; Cui R
Eur J Pharmacol; 2023 Oct; 957():175986. PubMed ID: 37598924
[TBL] [Abstract][Full Text] [Related]
3. Isolinderalactone sensitizes oxaliplatin-resistance colorectal cancer cells through JNK/p38 MAPK signaling pathways.
Kwak AW; Park JW; Lee SO; Lee JY; Seo JH; Yoon G; Lee MH; Choi JS; Shim JH
Phytomedicine; 2022 Oct; 105():154383. PubMed ID: 35987016
[TBL] [Abstract][Full Text] [Related]
4. Echinatin induces reactive oxygen species-mediated apoptosis via JNK/p38 MAPK signaling pathway in colorectal cancer cells.
Kwak AW; Lee JY; Lee SO; Seo JH; Park JW; Choi YH; Cho SS; Yoon G; Lee MH; Shim JH
Phytother Res; 2023 Feb; 37(2):563-577. PubMed ID: 36184899
[TBL] [Abstract][Full Text] [Related]
5. Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways.
Ni L; Zhu X; Zhao Q; Shen Y; Tao L; Zhang J; Lin H; Zhuge W; Cho YC; Cui R; Zhu W
Neoplasia; 2024 May; 51():100991. PubMed ID: 38507887
[TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin inhibited stem cell-like properties and enhanced oxaliplatin sensitivity of colorectal cancer via AKT/mTOR signaling.
Wang Y; Yang Z; Zhu W; Chen Y; He X; Li J; Han Z; Yang Y; Liu W; Zhang K
Drug Dev Res; 2023 Aug; 84(5):988-998. PubMed ID: 37132439
[TBL] [Abstract][Full Text] [Related]
7. Piperlongumine potentiates the antitumor efficacy of oxaliplatin through ROS induction in gastric cancer cells.
Zhang P; Shi L; Zhang T; Hong L; He W; Cao P; Shen X; Zheng P; Xia Y; Zou P
Cell Oncol (Dordr); 2019 Dec; 42(6):847-860. PubMed ID: 31493144
[TBL] [Abstract][Full Text] [Related]
8. Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer.
Zhang H; Wu J; Yuan J; Li H; Zhang Y; Wu W; Chen W; Wang C; Meng S; Chen S; Huo M; He Y; Zhang C
J Exp Clin Cancer Res; 2021 Aug; 40(1):260. PubMed ID: 34412665
[TBL] [Abstract][Full Text] [Related]
9. Krill oil extract suppresses the proliferation of colorectal cancer cells through activation of caspase 3/9.
Jayathilake AG; Kadife E; Luwor RB; Nurgali K; Su XQ
Nutr Metab (Lond); 2019; 16():53. PubMed ID: 31428181
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
11. Synergistic anticancer effect of docosahexaenoic acid and isoliquiritigenin on human colorectal cancer cells through ROS-mediated regulation of the JNK and cytochrome c release.
Jin H; Kim HS; Yu ST; Shin SR; Lee SH; Seo GS
Mol Biol Rep; 2021 Feb; 48(2):1171-1180. PubMed ID: 33502699
[TBL] [Abstract][Full Text] [Related]
12. Gambogenic acid induces Noxa-mediated apoptosis in colorectal cancer through ROS-dependent activation of IRE1α/JNK.
Zhao Q; Zhong J; Bi Y; Liu Y; Liu Y; Guo J; Pan L; Tan Y; Yu X
Phytomedicine; 2020 Nov; 78():153306. PubMed ID: 32854039
[TBL] [Abstract][Full Text] [Related]
13. Shikonin potentiates therapeutic efficacy of oxaliplatin through reactive oxygen species-mediated intrinsic apoptosis and endoplasmic reticulum stress in oxaliplatin-resistant colorectal cancer cells.
Zhang Z; Shen C; Zhou F; Zhang Y
Drug Dev Res; 2023 May; 84(3):542-555. PubMed ID: 36779379
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of oxaliplatin-induced colon cancer cell apoptosis by alantolactone, a natural product inducer of ROS.
Cao P; Xia Y; He W; Zhang T; Hong L; Zheng P; Shen X; Liang G; Cui R; Zou P
Int J Biol Sci; 2019; 15(8):1676-1684. PubMed ID: 31360110
[TBL] [Abstract][Full Text] [Related]
15. Dihydroartemisinin synergistically enhances the cytotoxic effects of oxaliplatin in colon cancer by targeting the PHB2-RCHY1 mediated signaling pathway.
Wang X; Zheng Y; Chai Z; Li J; Zhu C; Peng Y; Qiu J; Xu J; Liu C
Mol Carcinog; 2023 Mar; 62(3):293-302. PubMed ID: 36342357
[TBL] [Abstract][Full Text] [Related]
16. Dihydroartemisinin prompts amplification of photodynamic therapy-induced reactive oxygen species to exhaust Na/H exchanger 1-mediated glioma cells invasion and migration.
Hou K; Liu J; Du J; Mi S; Ma S; Ba Y; Ji H; Li B; Hu S
J Photochem Photobiol B; 2021 Jun; 219():112192. PubMed ID: 34000476
[TBL] [Abstract][Full Text] [Related]
17. Dihydroartemisinin induces apoptosis in human gastric cancer cell line BGC-823 through activation of JNK1/2 and p38 MAPK signaling pathways.
Zhang S; Shi L; Ma H; Li H; Li Y; Lu Y; Wang Q; Li W
J Recept Signal Transduct Res; 2017 Apr; 37(2):174-180. PubMed ID: 27401020
[TBL] [Abstract][Full Text] [Related]
18. miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression.
Zhou H; Lin C; Zhang Y; Zhang X; Zhang C; Zhang P; Xie X; Ren Z
Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28217977
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory effects of carnosic acid on cervical cancer cells growth by promoting apoptosis via ROS-regulated signaling pathway.
Su K; Wang CF; Zhang Y; Cai YJ; Zhang YY; Zhao Q
Biomed Pharmacother; 2016 Aug; 82():180-91. PubMed ID: 27470354
[TBL] [Abstract][Full Text] [Related]
20. A novel coordination complex of platinum (PT) induces cell death in colorectal cancer by altering redox balance and modulating MAPK pathway.
Al-Khayal K; Vaali-Mohammed MA; Elwatidy M; Bin Traiki T; Al-Obeed O; Azam M; Khan Z; Abdulla M; Ahmad R
BMC Cancer; 2020 Jul; 20(1):685. PubMed ID: 32703189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]